Panel: Unveiling Distinctions: Evaluating TCR-T Cell Therapies, CAR-T, TCR Bispecifics, & Antibody Mimetics for Tailored Therapeutic Advancements
Time: 3:00 pm
day: DAY ONE TRACK 3 A
Details:
- Quantifying Effectiveness: Comparing the relative affinities, potencies, and safety profiles of T-cell therapies, CAR-T, TCR bispecifics and antibody mimetics to discern their unique therapeutic characteristics
- Strategic Suitability: Assessing the optimal indications and patient populations where each TCR modality excels
- Beyond the Horizon: Exploring potential future modalities in the TCR therapy landscape, envisioning the untapped possibilities for further advancements in precision medicine
- The relevance of affinity maturation across modalities
